Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
RVMDW
#10880
Revolution Medicines, Inc. Common Stock
6.019
9
USD
+11.07%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+11.07%
Aylık Değişim
+238.20%
6 aylık değişim
+1781.22%
Yıllık Değişim
+9966.72%
Önceki Kapanış
5.420
0
Open
6.070
0
Bid
Ask
Low
5.770
0
High
6.070
0
Hacim
35
Piyasalar
ABD Borsası
Sağlık Hizmetleri
RVMDW
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
185.91 M
186.27 M
186.93 M
193.32 M
198.17 M
—
Valuation ratios
Enterprise value
—
—
—
—
—
—
Price to earnings ratio
-0.05
-0.01
-0.06
-0.06
-0.16
-0.28
Price to sales ratio
—
5.64
26.34
22.55
—
—
Price to cash flow ratio
-0.05
-0.01
-0.07
-0.07
-0.2
-0.35
Price to book ratio
0.01
0
0.01
0.01
0.11
0.12
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.08
-0.09
-0.1
-0.14
-0.15
-0.48
Return on equity %
-0.09
-0.1
-0.13
-0.19
-0.22
-0.65
Return on invested capital %
-309.76
—
—
—
-310.11
—
Gross margin %
—
100
100
100
100
400
Operating margin %
—
-18.99 K
-43.4 K
-50.12 K
-43.31 K
-155.81 K
EBITDA margin %
—
-19.51 K
-44.24 K
-50.57 K
-43.4 K
-157.72 K
Net margin %
—
-16.83 K
-40.62 K
-48.52 K
-43.7 K
-149.67 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
14.2
13.46
11.79
8.05
7.14
40.45
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.82
-1.03
-1.18
-1.1
-1.44
-4.75
EBIT per share
-1.29
-1.27
-1.4
-1.66
-1.9
-6.23
EBITDA per share
-1.33
-1.32
-1.43
-1.68
-1.91
-6.33
Total debt per share
—
—
—
—
—
—
Cash per share
13.65
11.18
11.33
10.21
10.65
43.37
Net current asset value per share
13.88
11.35
11.54
10.45
10.91
44.25
Tangible book value per share
13.08
10.67
9.52
8.07
8.21
36.46
Working capital per share
12.9
10.5
10.56
9.15
9.39
39.6
Book value per share
13.5
11.05
9.89
8.44
8.58
37.96
Haberler
Revolution Medicines: "Strong Buy" On Daraxonrasib Win And Expansions Underway (RVMD)
Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance
LABD: ETF To Benefit From Downturns In The Biotech Industry (NYSEARCA:LABD)
Janus Henderson Enterprise Fund Q4 2025 Portfolio Review
Immuneering: Strong Buy Despite Decline In Share Price On Atebimetinib Data (NASDAQ:IMRX)
LABU: The Risks And Rewards Of A Leveraged Biotechnology ETF (NYSEARCA:LABU)
Tango Therapeutics: PRMT5 Inhibitor Vopimetostat Approaches Pivotal Testing - Buy (TNGX)
Revolution Medicines, Inc. (RVMD) Q3 2025 Earnings Call Transcript
Revolution Medicines, Inc. (RVMD) Special Call - Slideshow (NASDAQ:RVMD)
Revolution Medicines, Inc. (RVMD) Q4 2024 Earnings Call Transcript